Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Echo Therapeutics (ECTE)

Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3
  • Shares Outstanding, K 12,630
  • Annual Sales, $ 0 K
  • Annual Income, $ -22,200 K
  • 60-Month Beta 6.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ECTE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 01/03/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +100.00%
on 08/31/21
0.0025 -92.00%
on 08/20/21
+0.0001 (+100.00%)
since 07/29/21
3-Month
0.0001 +100.00%
on 08/31/21
0.0300 -99.33%
on 06/15/21
-0.0218 (-99.09%)
since 05/18/21
52-Week
0.0001 +100.00%
on 08/31/21
0.2800 -99.93%
on 02/22/21
-0.0087 (-97.75%)
since 09/02/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Echo Therapeutics, Inc., a medical device and specialty pharmaceutical company, develops a non-invasive and wireless transdermal continuous glucose monitoring system for people with diabetes and for use in hospital critical care units in the United States. Its Symphony transdermal continuous glucose...

See More

Key Turning Points

3rd Resistance Point 0.0002
2nd Resistance Point 0.0002
1st Resistance Point 0.0002
Last Price 0.0002
1st Support Level 0.0002
2nd Support Level 0.0002
3rd Support Level 0.0002

See More

52-Week High 0.2800
Fibonacci 61.8% 0.1731
Fibonacci 50% 0.1400
Fibonacci 38.2% 0.1070
Last Price 0.0002
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar